KRYSTAL WOOLMAN: Open Payments
NPI 1538790985 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 19 payments from 7 companies in 2025. Trend: 2023 $1,725 · 2024 $561 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $94 |
| Vanda Pharmaceuticals Inc. | 3 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| ABBVIE INC. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Corium, LLC | 1 | $33 |
| Tris Pharma Inc | 1 | $14 |
Products named: FANAPT, Auvelity, REXULTI, VRAYLAR, CAPLYTA, Azstarys, Sunosi, Dyanavel XR.
Industry payments across TN — which companies pay providers there.
